Cargando…
A Preliminary Study of Different Treatment Strategies for Anxious Depression
BACKGROUND: Despite the best treatments, about 20% of patients with major depressive disorder (MDD) receiving drugs and psychological intervention show little or no improvement. There is no trial comparing different treatment methods in patients with anxiety/somatic subtype MDD. AIM: To compare the...
Autores principales: | Wang, Yun, Liu, Xiaohua, Peng, Daihui, Wu, Yan, Su, Yun’ai, Xu, Jia, Ma, Xiancang, Li, Yi, Shi, Jianfei, Cheng, Xiaojing, Rong, Han, Fang, Yiru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742615/ https://www.ncbi.nlm.nih.gov/pubmed/35018097 http://dx.doi.org/10.2147/NDT.S320091 |
Ejemplares similares
-
A Preliminary Randomized Controlled Trial of Different Treatment Regimens for Melancholic Depression
por: Wang, Yun, et al.
Publicado: (2021) -
TNF-α, IL-6 and hsCRP in patients with melancholic, atypical and anxious depression: an antibody array analysis related to somatic symptoms
por: Liu, Hongmei, et al.
Publicado: (2022) -
Abnormal white matter integrity in Chinese young adults with first-episode medication-free anxious depression: a possible neurological biomarker of subtype major depressive disorder
por: Xia, Weiping, et al.
Publicado: (2018) -
The Developmental and Translational Study on Biomarkers and Clinical Characteristics-based Diagnostic and Therapeutic Identification of Major Depressive Disorder: Study Protocol for a Multicenter Randomized Controlled Trial in China
por: Liu, Xiaohua, et al.
Publicado: (2020) -
P300 event-related potentials in patients with different subtypes of depressive disorders
por: Wang, Yun, et al.
Publicado: (2023)